Weekly Digest – 25-31 Mar 2023 Weekly Digest – 25-31 Mar 2023 31 Mar 2023: Breyanzi (Lisocabtagene Maraleucel) / 2L NHL / BMS: Granted Positive CHMP opinion in EU BMS announced positive CHMP opinion for Breyanzi to treat adult patients […]
Weekly Digest – 25-31 Mar 2023 Weekly Digest – 25-31 Mar 2023 29 Mar 2023: Osemitamab (TST001) / Pancreatic Cancer / Transcenta: US FDA granted Orphan Drug Designation FDA has granted Orphan Drug Designation to Osemitamab (TST001) for the treatment […]
Weekly Digest – 25-31 Mar 2023 Weekly Digest – 25-31 Mar 2023 27 Mar 2023: Pemazyre Oral/ Myeloid/Lymphoid Neoplasms (MLNs) / Incyte: Received MHLW approval in Japan Pemazyre’s MHLW approval was based on the Phase 2 FIGHT-203 Myeloid/Lymphoid Neoplasms (MLNs) […]
